NASDAQ: ADNAdvent Technologies Holdings Inc Stock
$0.18+0.01 (+5.88%)
Updated Apr 18, 2024
ADN Price
$0.18
Fair Value Price
$0.01
Market Cap
$11.13M
52 Week Low
$0.15
52 Week High
$1.13
P/E
-0.1x
P/B
0.34x
P/S
4.45x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.31M
Earnings
-$93.29M
Gross Margin
-56.3%
Operating Margin
-1,752.47%
Profit Margin
-1,756.9%
Debt to Equity
0.7
Operating Cash Flow
-$26M
Beta
0.23
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A
ADN Overview
Advent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets. It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems. The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, HT-PEM based membrane electrode assemblies, membranes, and electrodes. It serves stationary and portable power, automotive, aviation, energy storage, and sensor markets. The company is headquartered in Boston, Massachusetts.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ADN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ADN ($0.18) is overvalued by 1,251.78% relative to our estimate of its Fair Value price of $0.01 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ADN ($0.18) is not significantly undervalued (1,251.78%) relative to our estimate of its Fair Value price of $0.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ADN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ADN due diligence checks available for Premium users.
Be the first to know about important ADN news, forecast changes, insider trades & much more!
ADN News
Valuation
ADN fair value
Fair Value of ADN stock based on Discounted Cash Flow (DCF)
Price
$0.18
Fair Value
$0.01
Overvalued by
1,266.97%
ADN ($0.18) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ADN ($0.18) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ADN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ADN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.1x
Industry
30.85x
Market
41.33x
ADN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.34x
Industry
2.52x
ADN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ADN's financial health
Profit margin
Revenue
$1.3M
Net Income
-$11.8M
Profit Margin
-937.2%
ADN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ADN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$55.4M
Liabilities
$22.8M
Debt to equity
0.7
ADN's short-term assets ($23.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ADN's short-term assets ($23.52M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ADN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ADN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$7.4M
Investing
-$919.0k
Financing
$2.1M
ADN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ADN vs Renewable Energy Stocks
Advent Technologies Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.